Related Experiment Videos
[The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy]
K Rett1, M Wicklmayr, E Standl
1Medizinische Abteilung, Institut für Diabetesforschung am Krankenhaus München-Schwabing, Bundesrepublik Deutschland.
Wiener Klinische Wochenschrift
|January 1, 1994
Summary
Metabolic syndrome components increase risks for atherosclerosis and type 2 diabetes. Improving insulin sensitivity through early lifestyle interventions is key for primary prevention.
Area of Science:
- Metabolic disorders and cardiovascular health
Context:
- Metabolic syndrome components like obesity, dyslipidemia, hypertension, and glucose intolerance are linked to increased atheroma and type 2 diabetes risk.
- Skeletal muscle insulin resistance and compensatory hyperinsulinemia are central to most metabolic syndrome components, excluding hyperuricemia.
Purpose:
- To highlight the pathophysiological links between metabolic syndrome components, insulin resistance, and cardiovascular/diabetic risks.
- To emphasize the importance of early identification and intervention for primary prevention.
Summary:
- Metabolic syndrome components, including central obesity, dyslipidemia, hyperuricemia, hypertension, and glucose intolerance, are significant risk factors for atherosclerosis and type 2 diabetes.
- Insulin resistance in skeletal muscle, leading to hyperinsulinemia, underlies most metabolic syndrome features and contributes to hypertension and atherogenesis.
- Early identification of at-risk individuals and interventions to improve insulin action are crucial for preventing atherosclerosis and type 2 diabetes.
Impact:
- Early intervention targeting insulin action can mitigate the risks associated with metabolic syndrome, reducing the incidence of atherosclerosis and type 2 diabetes.
- An integrated lifestyle approach focusing on improving insulin sensitivity is vital for primary prevention strategies.